Jennifer Lachey Insider Trading $KROS Keros Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer Lachey.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer Lachey. Jennifer Lachey is Chief Scientific Officer in Keros Therapeutics, Inc. ($KROS).
Jennifer Lachey in Keros Therapeutics, Inc.
Trading Symbol: KROSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Lachey: Chief Scientific Officer
Holdings: 80,557 shares
Latest Transaction: Jun 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jennifer Lachey in Keros Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 129,705 | |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 52.13 | 219 | 11,416 | 77,907 | 78.1 K to 77.9 K (-0.28 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 51.73 | 898 | 46,454 | 78,126 | 79 K to 78.1 K (-1.14 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.37 | 1,533 | 77,217 | 79,024 | 80.6 K to 79 K (-1.90 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 80,557 | 77.9 K to 80.6 K (+3.40 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 500 | 150 | 7,793 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 500 | 150 | 7,793 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 6,220 | 684 | 0 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 6,220 | 684 | 0 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 132,355 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 132,355 | |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 500 | 150 | 77,907 | 77.4 K to 77.9 K (+0.65 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 500 | 150 | 77,907 | 77.4 K to 77.9 K (+0.65 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 6,220 | 684 | 77,407 | 71.2 K to 77.4 K (+8.74 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 6,220 | 684 | 77,407 | 71.2 K to 77.4 K (+8.74 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.00 | 2,650 | 132,500 | 71,187 | 73.8 K to 71.2 K (-3.59 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.00 | 2,650 | 132,500 | 71,187 | 73.8 K to 71.2 K (-3.59 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 73,837 | 71.2 K to 73.8 K (+3.72 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 73,837 | 71.2 K to 73.8 K (+3.72 %) |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 5,300 | 1,590 | 135,005 | |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 61.72 | 100 | 6,172 | 71,187 | 71.3 K to 71.2 K (-0.14 %) |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 61.08 | 729 | 44,527 | 71,287 | 72 K to 71.3 K (-1.01 %) |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 59.99 | 3,473 | 208,345 | 72,016 | 75.5 K to 72 K (-4.60 %) |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 59.10 | 998 | 58,982 | 75,489 | 76.5 K to 75.5 K (-1.30 %) |
Apr 14 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 5,300 | 1,590 | 76,487 | 71.2 K to 76.5 K (+7.45 %) |
Apr 02 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 9,996 | 1,100 | 0 | |
Apr 02 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 9,996 | 1,100 | 71,187 | 61.2 K to 71.2 K (+16.34 %) |
Mar 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 5,300 | 1,590 | 140,305 | |
Mar 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 65.47 | 4 | 262 | 61,191 | 61.2 K to 61.2 K (-0.01 %) |
Mar 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 64.72 | 3,557 | 230,209 | 61,195 | 64.8 K to 61.2 K (-5.49 %) |
Mar 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 63.99 | 1,739 | 111,279 | 64,752 | 66.5 K to 64.8 K (-2.62 %) |
Mar 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 5,300 | 1,590 | 66,491 | 61.2 K to 66.5 K (+8.66 %) |
Mar 01 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 33,200 | 3,652 | 9,996 | |
Mar 01 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 33,200 | 3,652 | 61,191 | 28 K to 61.2 K (+118.61 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 5,300 | 1,590 | 145,605 | |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 68.05 | 14 | 953 | 27,991 | 28 K to 28 K (-0.05 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 67.05 | 262 | 17,567 | 28,005 | 28.3 K to 28 K (-0.93 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 65.99 | 1,845 | 121,752 | 28,267 | 30.1 K to 28.3 K (-6.13 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 64.93 | 1,272 | 82,591 | 30,112 | 31.4 K to 30.1 K (-4.05 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 63.74 | 1,460 | 93,060 | 31,384 | 32.8 K to 31.4 K (-4.45 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 62.85 | 447 | 28,094 | 32,844 | 33.3 K to 32.8 K (-1.34 %) |
Feb 16 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 5,300 | 1,590 | 33,291 | 28 K to 33.3 K (+18.93 %) |
Jan 12 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | A | 70.93 | 42,250 | 2,996,793 | 42,250 | |
Apr 08 2020 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | A | 16.00 | 241,222 | 3,859,552 | 241,222 | |
Apr 08 2020 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | A | 16.00 | 241,222 | 3,859,552 | 241,222 |
Page: 1